Artificial Intelligence in Cardiology

Artificial Intelligence in Cardiology

Artificial Intelligence (AI) has the potential to revolutionize the field of cardiology by improving diagnostic accuracy, optimizing treatment plans, and facilitating personalized medicine. AI algorithms and tools can analyze large volumes of data, identify patterns and trends, and develop predictive models to guide the development of personalized treatment plans for patients. With the increasing prevalence of cardiovascular diseases, the need for more advanced and efficient AI-powered diagnostic tools increases that resulting in an increasing market for AI in cardiology. For instance, as per the World Health Organization (WHO), an estimated 17.9 million people die from cardiovascular diseases (CVDs), which are the main cause of death worldwide.

Artificial Intelligence in Cardiology Market is expected to grow at a strong CAGR of 38% during the forecast period owing the technological advancements and frequent product launches. For instance, In February 2023, Cardio Diagnostics Holdings launched PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary artery disease.

• Based on components, the market is segmented into hardware, software solutions, and services. The software segment held a dominant share in 2021. This is mainly due to innovation and development in this field. As the amount of data generated in cardiology continues to grow, the importance of software in analyzing and interpreting this data also increases. Further, the software includes machine learning algorithms and deep learning software. These algorithms enable the analysis of vast amounts of data, leading to more accurate diagnostic and predictive tools. As the amount of data generated in cardiology continues to grow, the importance of software in analyzing and interpreting this data also increases.
• Based on the application, the market is segmented into cardiac arrhythmias, stroke, cardiac heart disease, and others. The cardiac arrhythmias segment is expected to grow with a higher CAGR in the artificial intelligence in cardiology market during the forecast period. Arrhythmia is a condition where the heart beats irregularly, which can lead to serious health problems, including stroke and heart failure. The increasing prevalence of arrhythmia is an important reason for the market growth of the segment in artificial intelligence in the cardiology market. For instance, as per the CDC, an estimated 12.1 million people in the United States will have Atrial Fibrillation in 2030, and in 2019, AFib accounted for 183,321 deaths in the U.S.
• For a better understanding of the market adoption of the industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Rest of World. North American region was dominating the artificial intelligence in the cardiology market in 2021. This is mainly due to the increasing prevalence of the geriatric population and the rising prevalence of cardiovascular diseases among them is an important factor for the large market share of the region in the global market. For instance, as per Canadian Statistics, the population aged 85 and older is one of the fastest-growing age groups, with a 12% increase from 2016. Currently, 2.3% of the population is aged 85 and older.
• Some of the major players operating in the market include IDOVEN; CardiAI; Ultromics Limited; Arterys Inc; Cardiologs; UltraSight, DiA Imaging Analysis; HeartVista Inc; Viz.ai, Inc.; and RSIP Vision.